Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To detect coronary artery disease by both coronary and carotid artery imaging and myocardial perfusion imaging using a new low mechanical index real time system.
The objective of this clinical study will be to visualize both coronary and carotid arteries as well as detect myocardial perfusion following a routine intravenous injection of Definity (0.05-0.20 millimeters), Optison (0.1-0.4 millimeters) or PESDA (0.05-0.2 mL). Following these injections , we will attempt to Contrast Pulse Sequencing on the Siemens Acuson Sequoia system to image both the coronary and carotid arteries, as well as the Myocardial perfusion.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 Intravenous Optison Followed by Contrast Pulse Sequencing | Active Comparator | Administration of Optison (0.1-0.4 mL) intravenously followed by Contrast Pulse Sequencing to image both the coronary and carotid arteries. Use will depend on availability of the contrast for the given study Optison will not be used on patients with blood allergies or Jehovah Witnesses |
|
| 2 Intravenous Definity followed by Contrast Pulse Sequencing | Active Comparator | Intravenous injection of Definity (0.05-0.20 mL) followed by Contrast Pulse Sequencing to image both coronary and carotid arteries |
|
| 3 Intravenous PESDA followed by Contrast Pulse Sequencing | Active Comparator | Intravenous injection of PESDA at a rate of 0.05-0.20 mL followed by Contrast Pulse Sequencing image of coronary and carotid arteries PESDA will be used exclusively in patients who are eligible for other IRB studies |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Optison | Drug | 0.1-0.4 mL through intravenous injection at the beginning of the study. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Detection of coronary and carotid artery stenoses and perfusion defects during standard echocardiographic examination | To determine whether this imaging scheme can detect both coronary and carotid artery stenoses as well as perfusion defects during a standard echocardiographic examination | 2-4 months |
| Measure | Description | Time Frame |
|---|---|---|
| Visual analysis of coronary and carotid arteries and perfusion defects during standard echocardiogram examination | Visually analyze the coronary and carotid arteries as well as perfusion defects during a standard echocardiogram examination | immediate |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Thomas R Porter, MD | University of Nebraska | Principal Investigator |
Not provided
| ID | Term |
|---|---|
| D023921 | Coronary Stenosis |
| D016893 | Carotid Stenosis |
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C099458 | FS 069 |
| C042852 | perflutren |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Definity | Drug | intravenous injection at 0.05-0.20 mL |
|
| PESDA | Drug | intravenous injections dosage 0.05-0.20 mL |
|
|
| D014652 |
| Vascular Diseases |
| D002340 | Carotid Artery Diseases |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D001157 | Arterial Occlusive Diseases |